Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TASK-1 and TASK-3 potassium channels are members of the two-pore domain (K2P) potassium channel family, encoded by the genes KCNK3 and KCNK9, respectively[3][4]. They are pH-sensitive background channels that regulate the resting membrane potential in excitable and non-excitable cells, such as neurons, cardiac myocytes, and endocrine cells[3][4]. TASK-1 and TASK-3 form potassium-selective pores and can heterodimerize with related channels such as TASK-5[5]. They play crucial roles in the regulation of aldosterone secretion, neuronal oscillations, sleep behavior, vascular tone, and pulmonary artery function[1][2][3][4]. Dysregulation or mutations in these channels are linked to pulmonary hypertension, neurodevelopmental disorders (including Birk-Barel syndrome), and cardiovascular diseases[3][4]. Pharmacologically, they are sensitive to extracellular pH, volatile anesthetics (e.g., halothane), and specific small-molecule modulators, making them valuable therapeutic targets[2][3][4][5]. Safety concerns relate to their wide physiological roles and risks of unintentionally inducing diseases by incorrect modulation[3][4][5].
Positive allosteric modulation (activation of potassium currents) - Inhibition or activation by extracellular protons (pH-dependent gating) - Inhibitors reduce potassium efflux, increase depolarization - Activators increase potassium efflux, stabilize membrane potential
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TASK-1 potassium channel, TASK-3 potassium channel (TASK-1 (KCNK3), TASK-3 (KCNK9)).